DNA repair disease
MONDO:0021190A disease that has its basis in the disruption of DNA repair.
Also known as: DNA repair disorder, deficiency of DNA repair, disorder of DNA repair, DNA Repairs, deficient, DNA repair deficiency, DNA repair deficiency disorders, DNA repair, deficient, DNA repair-deficiencies
105 clinical trials for this condition and its sub-types, 13 tagged with DNA repair disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of DNA repair disease
-
Fanconi anemia 29 trials · 42 incl. sub-types
22 sub-types
- Fanconi anemia complementation group D1 6 trials
- Fanconi anemia complementation group A 4 trials
- Fanconi anemia complementation group E 4 trials
- Fanconi anemia complementation group N 2 trials
- Fanconi anemia, complementation group S 2 trials
- Fanconi anemia complementation group B 0 trials
- Fanconi anemia complementation group C 0 trials
- Fanconi anemia complementation group D2 0 trials
- Fanconi anemia complementation group F 0 trials
- Fanconi anemia complementation group G 0 trials
- Fanconi anemia complementation group I 0 trials
- Fanconi anemia complementation group J 0 trials
- Fanconi anemia complementation group L 0 trials
- Fanconi anemia complementation group O 0 trials
- Fanconi anemia complementation group P 0 trials
- Fanconi anemia complementation group Q 0 trials
- Fanconi anemia complementation group R 0 trials
- Fanconi anemia complementation group T 0 trials
- Fanconi anemia complementation group U 0 trials
- Fanconi anemia complementation group V 0 trials
- Fanconi anemia, complementation group W 0 trials
- Fanconi anemia, complementation group 10 0 trials
-
Mismatch repair cancer syndrome 5 trials · 36 incl. sub-types
4 sub-types
- Mismatch repair cancer syndrome 1 34 trials
- Mismatch repair cancer syndrome 2 0 trials
- Mismatch repair cancer syndrome 3 0 trials
- Mismatch repair cancer syndrome 4 0 trials
-
Cockayne syndrome 6 trials
4 sub-types
- Cockayne spectrum with or without cerebrooculofacioskeletal syndrome 0 trials
- Cockayne syndrome type 1 0 trials
- Cockayne syndrome type 2 0 trials
- Cockayne syndrome type 3 0 trials
-
Xeroderma pigmentosum 4 trials · 6 incl. sub-types
10 sub-types
- Xeroderma pigmentosum group F 1 trial
- Xeroderma pigmentosum variant type 1 trial
- Xeroderma pigmentosum group A 0 trials
- Xeroderma pigmentosum group B 0 trials
- Xeroderma pigmentosum group C 0 trials
- Xeroderma pigmentosum group D 0 trials
- Xeroderma pigmentosum group E 0 trials
- Xeroderma pigmentosum group G 0 trials
- Xeroderma pigmentosum, autosomal dominant, mild 0 trials
- Xeroderma pigmentosum, complementation group J 0 trials
-
Karyomegalic interstitial nephritis 2 trials
-
Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 0 trials · 2 incl. sub-types
-
COFS syndrome 1 trial
5 sub-types
- Cerebrooculofacioskeletal syndrome 1 0 trials
- Cerebrooculofacioskeletal syndrome 2 0 trials
- Cerebrooculofacioskeletal syndrome 3 0 trials
- Cerebrooculofacioskeletal syndrome 4 0 trials
- Xeroderma pigmentosum group G 0 trials
-
Nijmegen breakage syndrome 1 trial
-
UV-sensitive syndrome 0 trials
3 sub-types
- UV-sensitive syndrome 1 0 trials
- UV-sensitive syndrome 2 0 trials
- UV-sensitive syndrome 3 0 trials
-
Photosensitive trichothiodystrophy 0 trials
3 sub-types
- Trichothiodystrophy 1, photosensitive 0 trials
- Trichothiodystrophy 2, photosensitive 0 trials
- Trichothiodystrophy 3, photosensitive 0 trials
-
Promising drug combo targets aggressive brain cancers in youth
Disease control Not yet recruitingThis study is for adolescents and young adults (ages 12-39) newly diagnosed with aggressive brain tumors called high-grade glioma or DIPG. The goal is to see if a combination of two immunotherapy drugs (relatlimab and nivolumab, sold as Opdualag) is safe and tolerable when given …
Phase 2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Could a stem cell shot before birth fix fanconi anemia?
Disease control Not yet recruitingThis early-phase trial tests whether giving healthy stem cells from the mother to a fetus diagnosed with Fanconi anemia can safely improve the baby's blood cell production. The treatment is a one-time injection into the fetus during pregnancy. The study will enroll 12 pregnant wo…
Phase 1/2 • Sponsor: Agnieszka Czechowicz • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC